Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal Cancer [Phase 3]
Phase 3 trial comparing early chemotherapy based on CA 125 levels versus delayed chemotherapy in recurrent ovarian epithelial, fallopian tub…
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Chemotherapy With or Without Surgery in Treating Patients With Stage II or Stage III Ovarian Cancer [Phase 3]
Phase 3 trial comparing chemotherapy with versus without surgery for Stage II/III ovarian cancer has completed. The update notes completion …
-
CLINICAL_TRIALS trial_result · 2013-11-28Clinical Trial Update: Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies [Phase 2]
This report covers results from a Phase 2 trial using the CyberKnife stereotactic radiosurgery system to treat advanced or recurrent gynecol…
-
CLINICAL_TRIALS trial_result · 2013-11-27Clinical Trial Update: Phase 3 Randomized Study of Telcyta + Doxorubicin Versus Doxorubicin in Platinum Refractory or Resistant Ovarian Cancer [Phase 3]
Phase 3 randomized trial comparing Telcyta plus doxorubicin versus doxorubicin alone in platinum-refractory or resistant ovarian cancer has …
-
CLINICAL_TRIALS trial_result · 2013-11-26Clinical Trial Update: Hu3S193 in Treating Women With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
Phase 2 trial evaluating Hu3S193 in women with ovarian epithelial, primary peritoneal, or fallopian tube cancer has completed, and results h…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: S0025 Irinotecan in Treating Patients With Refractory Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
A Phase 2 clinical trial evaluating irinotecan in patients with refractory ovarian epithelial, primary peritoneal, or fallopian tube cancer …
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of MORAb-003 in Subjects With Advanced Ovarian Cancer [Phase 1]
A Phase 1 study evaluating safety, tolerability and pharmacokinetics of MORAb-003 (farletuzumab) in patients with advanced ovarian cancer re…
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer [Phase 2]
Phase 2 clinical trial update of a monoclonal antibody therapy for ovarian, fallopian tube, and primary peritoneal cancer sponsored by AltaR…
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: The Effects Of Yoga On Quality Of Life Among A Population Of Ovarian/ Fallopian Tube/ Primary Peritoneal Cancer Patients Receiving Chemotherapy: A Feasibility Study [NA]
A feasibility trial evaluating yoga to improve quality of life in patients with ovarian, fallopian tube, or primary peritoneal cancer receiv…
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Gene Therapy in Treating Women With Refractory or Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer [Phase 2]
Phase 2 clinical trial update investigating a gene therapy for women with refractory or relapsed ovarian epithelial cancer, fallopian tube c…
-
CLINICAL_TRIALS trial_result · 2013-10-25Clinical Trial Update: EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide [Phase 1]
Phase 1 trial evaluating EMD 273066 in EpCAM-positive recurrent ovarian, prostate, colorectal, or non-small cell lung cancer when first trea…
-
CLINICAL_TRIALS trial_result · 2013-10-24Clinical Trial Update: Motion Correction in Dynamic Contrast Enhanced Magnetic Resonance Imaging (MRI) in Ovarian Cancer: A Pilot Study
A completed pilot study evaluating motion correction techniques for dynamic contrast-enhanced MRI in patients with ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2013-10-11Clinical Trial Update: Avastin in Combination With Docetaxel in Ovarian/Fallopian Tube/Peritoneum Carcinoma [Phase 2]
Phase 2 trial evaluating Avastin (bevacizumab) in combination with docetaxel in ovarian, fallopian tube, and primary peritoneal cancers has …
-
CLINICAL_TRIALS trial_result · 2013-10-07Clinical Trial Update: BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors [Phase 2]
Phase 2 study of BI-2536 in patients with recurrent or metastatic solid tumors, including breast cancer, endometrial cancer, head and neck c…
-
CLINICAL_TRIALS trial_result · 2013-09-18Clinical Trial Update: Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [Phase 3]
Phase 3 trial evaluating carboplatin and paclitaxel with or without bevacizumab in advanced ovarian epithelial, primary peritoneal, or fallo…
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: High-Dose Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer That Has Been Removed During Surgery [Phase 3]
A Phase 3 trial comparing high-dose chemotherapy with standard chemotherapy in patients with stage III or stage IV ovarian epithelial cancer…
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors [Phase 3]
Phase 3 clinical trial evaluating observation and/or combination chemotherapy after surgery or biopsy in young patients with extracranial ge…
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Ovarian Cancer or Primary Peritoneal Cancer in Remission Following Surgery and Chemotherapy [Phase 3]
A phase 3 clinical trial update describes monoclonal antibody therapy for patients with ovarian cancer or primary peritoneal cancer in remis…
-
CLINICAL_TRIALS trial_result · 2013-09-17Clinical Trial Update: Methotrexate Plus Dipyridamole in Treating Patients With Advanced Ovarian Cancer [Phase 2]
Clinical trial update: a Phase 2 study of methotrexate plus dipyridamole in advanced ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2013-09-13Clinical Trial Update: A Phase I/II Study of CP-4055 in Patients With Platinum Resistant Ovarian Cancer [Phase 1, Phase 2]
A Phase I/II study of CP-4055 in platinum-resistant ovarian cancer has completed, as reported by sponsor Clavis Pharma.
-
CLINICAL_TRIALS trial_result · 2013-09-11Clinical Trial Update: The Effect of TRA-8 on Ovarian Cancer Tissue
This completed study evaluated the effect of TRA-8 on ovarian cancer tissue, reporting tissue-level results from a University of Alabama at …
-
CLINICAL_TRIALS trial_result · 2013-09-05Clinical Trial Update: WCC# 59 Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence Ovarian Cancer [NA]
Clinical trial update for hyperthermic intraperitoneal chemotherapy using carboplatin in first recurrence ovarian cancer; study terminated w…
-
CLINICAL_TRIALS trial_result · 2013-08-27Clinical Trial Update: Erlotinib or Observation in Treating Patients Who Have Undergone First-Line Chemotherapy for Ovarian Cancer, Peritoneal Cancer, or Fallopian Tube Cancer [Phase 3]
A Phase 3 trial comparing erlotinib to observation in patients who completed first-line chemotherapy for ovarian, fallopian tube, or primary…
-
CLINICAL_TRIALS trial_result · 2013-08-26Clinical Trial Update: Bryostatin 1 and Cisplatin in Treating Patients With Advanced Recurrent or Residual Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial of Bryostatin 1 in combination with Cisplatin for advanced recurrent or residual ovarian epithelial, fallopian tube, or primar…
-
CLINICAL_TRIALS trial_result · 2013-08-26Clinical Trial Update: Liposome-Encapsulated Doxorubicin Citrate With or Without Gemcitabine Hydrochloride in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer [Phase 2]
Phase 2 clinical trial evaluating liposome-encapsulated doxorubicin citrate with or without gemcitabine hydrochloride in patients with ovari…